Deutsche Rohstoff AG (DR0)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 90.80 |
|---|---|
| 52-week range | 43.60 – 117.80 |
| Return, 1 month / 3 months | +10.1% / +14.4% |
| Return, 1 year / 3 years | +100.8% / +208.4% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 49.5% |
| Worst drawdown (1 year) | -32.0% |
| Average daily value traded | 0.94M EUR |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Deutsche Rohstoff AG is a resource holding company based in Mannheim, Germany. It develops oil and gas projects, chiefly in the United States, through operating subsidiaries that acquire and develop producing fields. The company also holds interests in metals and mineral exploration, including tungsten and tin projects. Its customers are energy and commodity markets, and it works with partners and investors to fund and develop its resource assets.
Deutsche Rohstoff AG trades under the code DR0 on the Deutsche Börse Xetra in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Deutsche Rohstoff AG (DR0) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 90.80 on 27 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 248 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 100.8% and over the last three months it rose 14.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.0% | ||
| From 52-week high | -18.9% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.4% | ||
| 6-month return | -0.7% | ||
| 12-month return, skipping the last month | 82.4% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.0% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 0.94M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +8.6% |
|---|---|
| 1 month | +10.1% |
| 3 months | +14.4% |
| 6 months | −0.7% |
| 1 year | +100.8% |
| 3 years | +208.4% |
| 5 years | +336.3% |
Signals
| 50-day / 200-day average | 86.82 / 82.53 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.02 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jun 2026 | EUR 2.2500 |
| 18 Jun 2025 | EUR 2.0000 |
| 19 Jun 2024 | EUR 1.7500 |
| 30 Jun 2023 | EUR 1.3000 |
| 29 Jun 2022 | EUR 0.6000 |
| 16 Jul 2020 | EUR 0.0997 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.